Spain ranks slightly above average in the Severe Asthma Index overall, with moderate to strong scores across most categories. Spain reports that its population healthcare service needs are very well met as well as having a high level of drug and treatment access. However, access to biologics in Spain could be improved. Spain has a comparatively low estimated societal cost of severe asthma, but the disease burden could be further addressed through tackling risk factors such as adult obesity and tobacco use.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Spain
Provides further insights into how Spain scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
Information about the health impact of severe asthma and severe asthma comorbidities
Factors impacting prevention, management, and exacerbations of severe asthma
Aggregate score across the 5 categories.
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall